Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab for Relapsing-remitting Multiple Sclerosis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438161/2/. Accessed 27 April 2024.
Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438161/2/. Accessed April 27, 2024.
Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438161/2/
Rituximab for Relapsing-remitting Multiple Sclerosis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438161/2/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
ID - 438161
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438161/2/
DB - Evidence Central
DP - Unbound Medicine
ER -